Literature DB >> 10325712

Intrapericardial streptokinase in purulent pericarditis.

R Juneja1, S S Kothari, A Saxena, R Sharma, A Joshi.   

Abstract

Six consecutive children with proven purulent pericarditis were treated with pericardial irrigation with streptokinase. Mean (SD) 861 (678) ml (range 240-2000) of thick purulent fluid was drained, and five children had complete clearance of the pus within 3-8 days. One child developed intrapericardial haemorrhage with a submitral pseudoaneurysm and underwent patch closure of the neck of the aneurysm as well as anterior pericardiectomy. Follow up of 13 to 30 months revealed no pericardial constriction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325712      PMCID: PMC1717856          DOI: 10.1136/adc.80.3.275

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Purulent pericarditis treated with streptokinase-streptodornase.

Authors:  B B ROY
Journal:  J Indian Med Assoc       Date:  1955-01-01

2.  Animal model of acute pericarditis and its progression to pericardial fibrosis and adhesions: ultrastructural studies.

Authors:  L V Leak; V J Ferrans; S R Cohen; E E Eidbo; M Jones
Journal:  Am J Anat       Date:  1987-12

Review 3.  Right atrial thrombus associated with pyopericardium.

Authors:  D M Rao; S Singh; L Kumar
Journal:  Indian Pediatr       Date:  1994-11       Impact factor: 1.411

4.  Diagnosis and management of purulent pericarditis. Experience with pericardiectomy.

Authors:  A A Majid; A Omar
Journal:  J Thorac Cardiovasc Surg       Date:  1991-09       Impact factor: 5.209

5.  Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.

Authors:  K Peuhkurinen; L Risteli; A Jounela; J Risteli
Journal:  Am Heart J       Date:  1996-01       Impact factor: 4.749

6.  Treatment of exudative fibrinous pericarditis with intrapericardial urokinase.

Authors:  W B Winkler; R Karnik; J Slany
Journal:  Lancet       Date:  1994-12-03       Impact factor: 79.321

  6 in total
  7 in total

1.  Acute purulent pericarditis in pneumococcal meningitis.

Authors:  Martin E G Blohm; Horst Schroten; Andreas Heusch; Andreas Christaras; Mario Micek; Juergen Wintgens; Ertan Mayatepek; Thomas Hoehn
Journal:  Intensive Care Med       Date:  2005-06-24       Impact factor: 17.440

2.  Bacterial pericarditis presenting as hemorrhagic pericardial effusion in a 6-year-old girl.

Authors:  Anita Saxena; Navneet Singh; S Ramakrishnan; Shyamsunder Kothari
Journal:  Ann Pediatr Cardiol       Date:  2008-01

Review 3.  Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis.

Authors:  Pascal Augustin; Mathieu Desmard; Pierre Mordant; Sigismond Lasocki; Jean-Michel Maury; Nicholas Heming; Philippe Montravers
Journal:  Crit Care       Date:  2011-04-20       Impact factor: 9.097

4.  Successful Management of an Occult Cardiac Tamponade with Prompt Surgical Intervention and a Novel, Defined Pericardial Irrigation Protocol.

Authors:  Saleem Jahangeer; Rebecca Emily Gardiner; Patrick Forde; John Hinchion
Journal:  Thorac Cardiovasc Surg Rep       Date:  2015-03-31

Review 5.  Clinical Presentation and Management of Methicillin-Resistant Staphylococcus aureus Pericarditis-Systematic Review.

Authors:  Milan Radovanovic; Marija Petrovic; Richard D Hanna; Charles W Nordstrom; Andrew D Calvin; Michel K Barsoum; Natasa Milosavljevic; Djordje Jevtic; Mladen Sokanovic; Igor Dumic
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-30

6.  A prospective investigation into the effect of colchicine on tuberculous pericarditis.

Authors:  Jurgens Jacobus Liebenberg; Catherine Jane Dold; Lourens Rasmus Olivier
Journal:  Cardiovasc J Afr       Date:  2016 Nov/Dec       Impact factor: 1.167

7.  Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series.

Authors:  Małgorzata Dybowska; Monika Szturmowicz; Lucyna Opoka; Piotr Rudziński; Witold Tomkowski
Journal:  BMC Cardiovasc Disord       Date:  2020-08-27       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.